Philadelphia partner Kathryn Doyle, head of the Life Sciences Team, will speak on a panel “You Can’t Patent That! Can You?” at the AUTM Meeting. The panel, which includes in-house pharma counsel and leading practitioners in the electronic/computer law and biotechnology IP arenas, will summarize the trends and most recent landmarks - cases, regulations and proposed legislation - in the rapidly evolving area of "patentable subject matter."